A Phase 1/2A Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-C3 in Adult Healthy Volunteers and in Adult Patients with Complement-Mediated Renal Disease

  • Ryan, Jessica (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

Monash Health Local Reference: RES-22-0000-411A
NMA SSA Reference Number: SSA/87285/MonH-2023-376549(v1)
HREC Reference Number: HREC/87285/MonH-2022-337201(v2)
StatusActive
Effective start/end date14/06/23 → 13/06/28